David Johnson
Directeur/Membre du Conseil chez CARIBOU BIOSCIENCES, INC.
Fortune : - $ au 30/04/2024
Postes actifs de David Johnson
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| CARIBOU BIOSCIENCES, INC. | Directeur/Membre du Conseil | 11/05/2022 | - |
| Independent Dir/Board Member | 11/05/2022 | - |
Historique de carrière de David Johnson
Anciens postes connus de David Johnson
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| GLOBAL BLOOD THERAPEUTICS, INC. | Corporate Officer/Principal | 12/03/2018 | 01/12/2022 |
| GILEAD SCIENCES, INC. | Sales & Marketing | 01/01/2003 | 01/01/2018 |
Formation de David Johnson
| University of Puget Sound | Undergraduate Degree |
| Kenan-Flagler Business School | Masters Business Admin |
Statistiques
Internationale
| Etats-Unis | 6 |
Opérationnelle
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
| Masters Business Admin | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| CARIBOU BIOSCIENCES, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Global Blood Therapeutics, Inc.
 Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir, and David R. Phillips in February 2011 and is headquartered in South San Francisco, CA. | Health Technology |
- Bourse
- Insiders
- David Johnson
- Expérience
